Norlase Launches LYNX, a Revolutionary Portable Laser Indirect Ophthalmoscope
On January 27, 2025, Norlase, a leading global manufacturer of ophthalmic lasers, proudly announced the launch of the LYNX™, the world’s first and only pattern scanning laser indirect ophthalmoscope (LIO). This groundbreaking device has swiftly gained recognition as it received FDA 510(k) clearance and CE marking, paving the way for its immediate commercial release. The LYNX offers a battery-powered solution, granting surgeons unparalleled mobility and flexibility during procedures. Unlike traditional systems that require external laser sources, this innovative ophthalmoscope integrates the laser and display module directly into an ergonomic headset, allowing doctors to navigate their workspace freely while delivering effective treatments.
Oliver Hvidt, CEO and co-founder of Norlase, underscored the significance of time for today’s ophthalmologists, stating, "Since the introduction of pattern lasers over 15 years ago, physicians have been anticipating the arrival of an efficient LIO. With LYNX, we are answering that call. Faster LIO treatments lead to reduced ergonomic strain, improved patient interactions, and more productive workdays that conclude on schedule." This sentiment carries immense weight, as LYNX marks Norlase’s fourth product launch in merely five years, demonstrating the company’s commitment to simplifying ophthalmological practices while maximizing both doctor comfort and treatment efficacy.
The LYNX has garnered enthusiastic feedback from its initial users, with Dr. Daniel Diaz of Retina Consultants in Miami remarks on the device’s cutting-edge functionality and design. He commented, "This innovative device merges the speed and efficiency of pattern laser technology with unmatched portability and comfort, setting a new benchmark for laser indirect treatments." Dr. Diaz added, "Its portability and robust modeling options significantly enhance the pace and quality of my retinal treatment sessions."
Yet another testament to Norlase's relentless pursuit of innovation, LYNX boasts a compact, portable, and cost-effective profile, ensuring advanced laser technology reaches ophthalmologists globally. Here are some key features of the LYNX Pattern Scanning LIO:
Founded in Denmark, Norlase is dedicated to advancing laser solutions for the treatment of retinal diseases and glaucoma. The company comprises a team of world-class experts in ophthalmology, laser technology, medical device development, and customer service. The mission of Norlase is to enhance efficiency in practice, patient care, and comfort for ophthalmologists everywhere. Notable products in Norlase’s portfolio include LEAF, a laser photocoagulator that is ten times smaller than existing systems, LION, the first fully integrated green laser and LIO, ECHO, the world’s first ultra-portable pattern-scanning laser, and now LYNX, the first fully integrated LIO scanning device. For more information about Norlase and its revolutionary products, please visit their website at norlase.com.
Oliver Hvidt, CEO and co-founder of Norlase, underscored the significance of time for today’s ophthalmologists, stating, "Since the introduction of pattern lasers over 15 years ago, physicians have been anticipating the arrival of an efficient LIO. With LYNX, we are answering that call. Faster LIO treatments lead to reduced ergonomic strain, improved patient interactions, and more productive workdays that conclude on schedule." This sentiment carries immense weight, as LYNX marks Norlase’s fourth product launch in merely five years, demonstrating the company’s commitment to simplifying ophthalmological practices while maximizing both doctor comfort and treatment efficacy.
The LYNX has garnered enthusiastic feedback from its initial users, with Dr. Daniel Diaz of Retina Consultants in Miami remarks on the device’s cutting-edge functionality and design. He commented, "This innovative device merges the speed and efficiency of pattern laser technology with unmatched portability and comfort, setting a new benchmark for laser indirect treatments." Dr. Diaz added, "Its portability and robust modeling options significantly enhance the pace and quality of my retinal treatment sessions."
Yet another testament to Norlase's relentless pursuit of innovation, LYNX boasts a compact, portable, and cost-effective profile, ensuring advanced laser technology reaches ophthalmologists globally. Here are some key features of the LYNX Pattern Scanning LIO:
- - The laser, scanner, and distribution system are fully integrated within a lightweight headset.
- - Battery power supply offers unmatched portability and treatment flexibility.
- - A comprehensive range of patterns is available, ranging from grids of 2x2 to 5x5, triple arcs, and circles.
- - It features simplyCLEAR safety filters for optimal visualization.
- - Multilingual voice commands facilitate seamless operation of patterns and settings.
Founded in Denmark, Norlase is dedicated to advancing laser solutions for the treatment of retinal diseases and glaucoma. The company comprises a team of world-class experts in ophthalmology, laser technology, medical device development, and customer service. The mission of Norlase is to enhance efficiency in practice, patient care, and comfort for ophthalmologists everywhere. Notable products in Norlase’s portfolio include LEAF, a laser photocoagulator that is ten times smaller than existing systems, LION, the first fully integrated green laser and LIO, ECHO, the world’s first ultra-portable pattern-scanning laser, and now LYNX, the first fully integrated LIO scanning device. For more information about Norlase and its revolutionary products, please visit their website at norlase.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.